SMTL ID : 5kzc.3 (2 other biounits)

Crystal structure of an HIV-1 gp120 engineered outer domain with a Man9 glycan at position N276, in complex with broadly neutralizing antibody VRC01

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.25 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN.1: 9 residues within 4Å: Chain B: N.79 Chain C: Y.28, G.29, S.30, R.64, W.65, G.66, Y.69, Y.89 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:G.29, C:R.64, C:R.64

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jardine, J.G. et al., Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design. Plos Pathog. (2016)

Release Date

2016-08-10

Peptides

VRC01 Fab heavy chain: A
Engineered outer domain of gp120: B
VRC01 Fab light chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
F

C
G

VRC01 Fab heavy chain

Engineered outer domain of gp120

VRC01 Fab light chain

Related Entries With Identical Sequence